ALOX5AP gene variants and risk of coronary artery disease: An angiography-based study

European Journal of Human Genetics

Volumn 15, Issue 9, 2007, Pages 959-966

  Girelli, Domenico ^a   Martinelli, Nicola ^a   Trabetti, Elisabetta ^a   Olivieri, Oliviero ^a   Cavallari, Ugo ^a   Malerba, Giovanni ^a   Busti, Fabiana ^a   Friso, Simonetta ^a   Pizzolo, Francesca ^a   Pignatti, Pier Franco ^a   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

CARRIER PROTEINS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 34548157531     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201854     Document Type: Article

References (29)

1. Watkins H, Farrall M: Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 2006; 7: 163-173.
2. Lusis AJ, Fogelman AM, Fonarow GC: Genetic basis of atherosclerosis, Part I, New genes and pathways. Circulation 2004; 110: 1868-1873.
3. Wang Q: Molecular genetics of coronary artery disease. Curr Opin Cardiol 2005; 20: 182-188.
4. Helgadottir A, Manolescu. A, Thorleifsson G et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233-239.
5. Dixon RAF, Diehl RE, Opas E et al: Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 1990; 343: 282-284.
6. Miller DK, Gillard JW, Vickers PJ et al: Identification and isolation of a membrane protein necessary for leukotriene production. Nature 1990; 343: 278-281.
7. Spanbroek R, Grabner R, Lotzer K et al: Expanding expression of 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 2003; 100: 1238-1243.
8. Qiu H, Gabrielsen A, Agardh HE et al: Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006; 103: 8161-8166.
9. Mehrabian M, Allayee H, Wong J et al: Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002; 91: 120-126.
10. Zhao L, Funk CD: Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 2004; 14: 191-195.
11. Löhmussaar E, Gschwendtner A, Mueller JC et al: ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005; 36: 731-736.
12. Meschia JF, Brott TG, Brown RD et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 2005; 58: 351-361.
13. Zee RY, Cheng S, Hegener HH, Erlich HA, Ridker PM: Genetic variants of arachidonate 5-lipoxygenase activating protein and risk of incident myocardial infarction and ischemic stroke. Stroke 2006; 37: 2007-2011.
14. Girelli D, Russo C, Ferraresi P et al: Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-780.
15. Devlin B, Risch N: A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-322.
16. Lake SL, Lyon H, Tantisira K et al: Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 56-65.
17. Gabriel SB, Schaffner SF, Nguyen H et al: The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
18. Kajimoto K, Shioji K, Ishida C et al: Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population. Circ J 2005; 69: 1029-1034.
19. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
20. SamuelssMn B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-575.
21. Helgadottir A, Manolescu A, Helgason A et al: A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006; 38: 68-74.
22. Dwyer JH, Allayee H, Dwyer KM et al: Arachidonate 5-lipoxigenase promoter genotype, dietary arachidonic acid and atherosclerosis. N Engl J Med 2004; 350: 29-37.
23. Funk CD: Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 2005; 4: 664-672.
24. Steinberg D: At last, direct evidence that lipoxygenases play a role in atherogenesis. J Clin Invest 1999; 103: 1487-1488.
25. Lötzer K, Funk CD, Habenicht AJR: The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 2005; 1736: 30-37.
26. Lusis AJ: Atherosclerosis. Nature 2000; 407: 233-241.
27. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
28. Colhoun HM, McKeigue PM, Davey Smith G: Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-872.
29. Helgadottir A, Gretarsdottir S, St Clair D et al: Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005; 76 505-509.